Export of 160 antipsychotic presentations banned

Infarmed has prohibited the export of over 160 presentations of quetiapine and around 50 other medications, including antibiotics and cancer treatments, effective Friday. This decision is due to supply issues linked to a contamination incident at a manufacturer in Greece. The list includes drugs that faced shortages in October and those supplied under Exceptional Use Authorization. The suspension also affects 15 presentations of estradiol. Infarmed is actively monitoring medication availability to prevent critical shortages and collaborates with European authorities for information sharing on supply issues.